POSTER SESSION II
Monday, February 13, 2006   1:00 - 4:30 PM
Exhibit Level
GYNECOLOGIC PATHOLOGY
105
Promoter Hypermethylation Of p16INK4A Is A Frequent And Early Event In Vulvar Carcinogenesis And Correlates With p16 Expression In Squamous Cell Carcinoma
(899)
A Ribe, E Lerma, Ll Catasus, J Prat - Hospital Sant Pau, Autonomous University, Barcelona, Spain
106
A proposed Classification of Invasive Patterns in Vulvar Squamous Carcinoma and Their Influence on the Depth of Tumor Invasion and Disease Recurrence.
(942)
BJ Yoder, NA Massoll, EJ Wilkinson - University of Florida, Gainesville, FL
107
Alterations Of The Tumor Suppressor Gene FHIT In Vulvar Cancer
(849)
ME Kahn, G Ambartsumyan, C Aoyama, S Natarajan, RL Balwin, BY Karlan, CH Holschneider - Cedars-Sinai Medical Center, UCLA Medical Center, Los Angeles, CA; Oliveview - UCLA Medical Center, Sylmar, CA
108
CD10 Immunostaining Aids in Distinguishing Trophoblastic Lesions from Squamous Epithelium in Endocervical Curettage
(834)
JM Hall, BL Strauss, JC Shaw - Wilford Hall Medical Center, San Antonio, TX
109
Low Grade Squamous Intraepithelial Lesions of the Cervix with Marked Cytologic Atypia - Histologic Follow up and Human Papillomavirus (HPV) Genotyping
(889)
K Park, D Hileeto, LH Ellenson, EC Pirog - Memorial Sloan-Kettering Cancer Center, Weill Medical College of Cornell University, New York, NY
110
Spontaneous Regression And Progression Of Low-Grade Squamous Intraepithelial Lesions Of The Uterine Cervix. A Follow-Up Study
(887)
J Ordi, LM Puig-Tintoré, L Quinto, R Esteve, M Solé, E Campo - IDIBAPS-Hospital Clinic, Barcelona, Spain; IDIBAPS-Hospital Clinic, Barcelona, Spain
111
Residual/Recurrent Disease After Loop Electrosurgical Excision Procedure Of Low-Grade Cervical Intraepithelial Neoplasia (CIN 1)
(857)
S Landolfi, I Alonso, A Torné, LM Puig-Tintoré, R Esteve, L Quinto, E Campo, J Ordi - IDIBAPS-Hospital Clinic, Barcelona, Spain; IDIBAPS-Hospital Clinic, Barcelona, Spain
112
Persistence Of An Identical Human Papillomavirus High Risk Type Before And After Conization: It Is An Alarm For Progressive Disease. A Retrospective Study
(888)
BC Padberg, DR Zimmermann, N Kurzen, S Welti - University, Zurich, Switzerland
113
Atypical Immature Metaplasia: Longitudinal Follow Up and Outcome Predictors
(816)
MA Duggan, M Akbari, AT Magliocco - University of Calgary, Calgary, AB, Canada
114
Comparison Of Inter And Intra-Observer Reproducibility Of Evaluating Cervical Dysplasia In HE Stained And p16 Immunostained Sections
(794)
B Behmaram, P Kotov, Z Basir, AF Cafaro, L Novoa-Takara, VB Shidham - Medical College of Wisconsin, Milwaukee, WI
115
p16 Staining Profile Of Biopsy Negative High Risk HPV Positive Women
(790)
SR Anderson, L Simmons-Arnold, ML Harmon - University of Vermont College of Medicine, Burlington, VT
116
Cytomorphologic Features of Endocervical Cells in HPV Positive Women
(878)
C Meroueh, KJ Jabbar, MZ Sharaf El-Dean, MM El-Fakharany, PF Mazzara - St John Hospital & Medical Center, Detroit, MI
117
Pathological Study of Endocervical Gland Involvement by Cervical Intraepithelial Neoplasia and Microinvasive Squamous Cell Carcinoma: MIB-1 Immunostaining Is a Useful Marker for Pathological Diagnosis from the Gland Involvement Site
(852)
M Kimura, T Matsumoto, H Sonoue, D Ogishima, K Kinoshita, K Suda - Juntendo University, Tokyo, Japan
118
Comparison of p16 and KOC Expression in Benign Glandular Epithelium and Adenocarcinoma in Situ of the Uterine Cervix
(865)
C Li, L Kordunsky, A Fischer, K Dresser - University of Massachusetts Medical School, Worcester, MA
119
Staining for p16 of Cervical Mesonephric Remnants and Hyperplasia: A Potential Diagnostic Pitfall
(925)
AM Truskinovsky, EB Stelow, J Jessurun, SE Pambuccian - University of Minnesota, Minneapolis, MN; University of Virginia, Charlottesville, VA
120
Fragile Histidine Triad Gene (FHIT) And p16 Expression In Endocervical Glandular Neoplasia
(854)
E Kling, G Jockle, OB Ioffe - University of Maryland School of Medicine, Mercy Medical Center, Baltimore, MD
121
Expression of 14-3-3Γ Protein in Endocervical Glandular Lesions
(879)
Y Mikami, T Kiyokawa, H Katsushima, T Suzuki, T Manabe - Kyoto University Hospital, Kyoto, Japan; Jikei University Medical School, Minato-ward, Tokyo, Japan; Tohoku University Graduate School of Medical Science, Sendai, Miyagi, Japan
122
Mammaglobin Expression in Benign and Neoplastic Endocervix and Endometrium
(886)
K Onuma, DJ Dabbs, R Bhargava - Magee Womens Hospital of University of Pittsburgh Medical Center, Pittsburgh, PA
123
The Utility Of HPV Testing In Cases Of Carcinomas That Involve The Endocervix And Endometrium
(891)
JA Plaza, GJ Nuovo - The Ohio State University Medical Center, Columbus, OH
124
Endometrioid Adenocarcinoma Involving the Endometrium and the Cervix: One Tumor or Two Independent Tumors?
(845)
L Jiang, A Malpica, M Deavers, G Nuovo, M Merino, EG Silva - MD Anderson Cancer Center, Houston, TX; Ohio University, Columbus, OH; National Cancer Institute, Bethesda, MD
125
Diffuse p16 Expression Distinguishes Uterine Serous Carcinoma (USC) From Uterine Endometrioid Carcinoma Of Endometrial Origin (UEC) But Not HPV-Related Endocervical Adenocarcinoma (ECC)
(941)
A Yemelyanova, H Ji, BM Ronnett - Johns Hopkins Hospital, Baltimore, MD
126
Immunohistochemical Evaluation of Endometrial Adenocarcinoma with Emphasis on the Differential Diagnosis with Endocervical Adenocarcinoma
(898)
MD Reid-Nicholson, P Iyengar, A Ali, RA Soslow - Memorial Sloan-Kettering Cancer Center, New York, NY
127
Tissue Expression Of p16 In Benign And Malignant Endometria
(796)
R Bhargava, E Elishaev - Magee-Womens Hospital of University of Pittsburgh Medical Center, Pittsburgh, PA
128
miRNA Expression Signatures in Cervical Cancer
(874)
CM Martin, K Astbury, R Henfrey, O Sheils, M Gallagher, C Heffron, C Logan, JJ O'Leary - Trinity College, Dublin, Dublin, Ireland; Coombe Women's Hospital, Dublin 8, Ireland; Applied Biosystems, Warrington, Cheshire, United Kingdom; OLHSC, Dublin, Ireland
129
Identification Of Cell Cycle Regulatory Molecules As Biomarkers In Cervical Cancer Using Gene Expression Profiling
(792)
K Astbury, CM Martin, P Smyth, JJ O'Leary - Coombe Women's Hospital, Dublin 8, Ireland; Trinity College Dublin, Dublin 2, Ireland
130
Phosphorlyated H2AX Expression In Cervical Neoplasia
(803)
T Chang, A Fahey, A Khramtsov, S Chmura, AG Montag - University of Chicago, Chicago, IL; Marquete University, Milwaukee, WI
131
Negative Sentinel Lymph Nodes Accurately Predict Negative Status Of Pelvic Lymph Nodes In Uterine Cervix Carcinoma
(892)
I Popa, M Plante, M-C Renaud, M Roy, B Tetu - Laval University, Quebec, QC, Canada
132
Expression of Carbonic Anhydrases in Patients with Uterine Cervix Cancer: An Immunohistochemical Analysis and Correlation with Lymph Node Metastases
(860)
S Lee, EK Hong, SS Seo, SY Park, JY Kim - National Cancer Center, Goyang-si, Gyeonggi-do, Republic of Korea
133
Cell Signaling Transduction Pathways In Carcinomas Of The Uterine Cervix
(826)
V Fumanal, A Garcia, J Castellvi, C Ruiz-Marcellan, R Verges, J Giralt, S Ramon y Cajal - Hospital San Pere de Ribes, San Pere de Ribes, Vall Hebron University Hospital, Vall Hebron University Hospital, Barcelona, Spain